Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04181944 · ClinicalTrials.gov registry record · NA

Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)

A NA study, sponsored by Memorial Healthcare System.

Completed
Registry status
NA
Development phase
115
Enrollment target

NCT04181944 is a NA study that has completed, run by Memorial Healthcare System. The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04181944, a NA study, has completed, sponsored by Memorial Healthcare System.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target

Study Summary

The purpose of this study is to assess the potential interventions of exercises in adults with sickle cell anemia (SCA) and cardiopulmonary disease; only including the more severe genotypes of sickle cell disease.

Interventions

  • OTHER Exercise Treatment Group

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2020-06-14
Est. Completion 2022-10-01
Phase NA

Sponsor

Memorial Healthcare System

7 total trials

What the Registry Record Tells You About NCT04181944

The ClinicalTrials.gov registry entry for NCT04181944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Healthcare System, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Exercise Treatment Group is the first listed.

NCT04181944 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04181944 about?

NCT04181944 is a clinical study titled "Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)". The purpose of this study is to assess the potential interventions of exercises in adults with sickle cell anemia (SCA) and cardiopulmonary disease; only including the more severe genotypes of sickle cell disease.

What is the current status of trial NCT04181944?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2020-06-14. Estimated completion is 2022-10-01.

What interventions are being tested in trial NCT04181944?

The interventions under investigation include: Exercise Treatment Group (OTHER).

Who is sponsoring clinical trial NCT04181944?

This trial is sponsored by Memorial Healthcare System, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.